berberine has been researched along with glycoprotein e2, hepatitis c virus in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hung, TC; Jassey, A; Lin, CC; Lin, CJ; Lin, LT; Liu, CH; Wang, JY; Wong, SH; Yen, MH | 1 |
1 other study(ies) available for berberine and glycoprotein e2, hepatitis c virus
| Article | Year |
|---|---|
Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein.
Topics: Antiviral Agents; Berberine; Cells, Cultured; Hepacivirus; Hepatitis C; Hepatocytes; Host-Pathogen Interactions; Humans; Molecular Docking Simulation; Molecular Targeted Therapy; Viral Envelope Proteins; Virus Internalization; Virus Replication | 2019 |